Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | 3 | Unknown | — |
On day 14 the patient was incorrectly given HyperRab (HRIG) instead of fourth RabAvert dose; Case reference number US-BN-2024-002522 is a spontaneous case initially received from a pharmacist via Med Communications (reference number: USBAV24-2423) on 18-Sep-2024 and concerns a 32-year-old male patient. The patient's medical history and concomitant medication details were not provided. On an unspecified date, the patient was exposed to a bat. On an unspecified date, reported as day zero, unknown amount of time after animal exposure, the patient was vaccinated with the first dose of RabAvert (batch number: unknown), at an unknown dose, route, and site of administration for post-exposure. On an unspecified date, reported as day three, unknown amount of time after animal exposure, the patient was vaccinated with the second dose of RabAvert (batch number: unknown), at an unknown dose, route, and site of administration. On an unspecified date, reported as day seven, unknown amount of time after animal exposure, the patient was vaccinated with the third dose of RabAvert (batch number: unknown), at an unknown dose, route, and site of administration. On an unspecified date, reported as day 14, unknown amount of time after animal exposure, the patient was incorrectly given HyperRab (HRIG; immunoglobulin human anti-rabies; batch number: unknown), at an unknown dose, route, or site of administration for post-exposure, instead of fourth dose of RabAvert (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to the RabAvert vaccination. No further information was provided.; Reporter's Comments: A 32-year-old male patient was incorrectly given HyperRab, reported as on the day 14, for post-exposure, instead of the fourth dose of RabAvert, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to the RabAvert vaccination. Inappropriate schedule of product administration is considered as unlisted per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A 32-year-old male patient was incorrectly given HyperRab, reported as on the day 14, for post-exposure, instead of the fourth dose of RabAvert, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to the RabAvert vaccination. Inappropriate schedule of product administration is considered as unlisted per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None
HYPERRAB